These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29853726)

  • 1. What is the role of angiotensin receptor blockers in treatment of hyperuricemia coexisting with arterial hypertension?
    Nieradko-Iwanicka B
    Reumatologia; 2018; 56(2):106-110. PubMed ID: 29853726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials.
    Takahashi T; Beppu T; Hidaka Y; Hosoya T
    Clin Exp Hypertens; 2021 Nov; 43(8):730-741. PubMed ID: 34425059
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lozartan potential in hyperuricemia correction].
    Ter Arkh; 2011; 83(10):45-8. PubMed ID: 22185025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics.
    Rayner BL; Trinder YA; Baines D; Isaacs S; Opie LH
    Am J Hypertens; 2006 Feb; 19(2):208-13. PubMed ID: 16448895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension.
    Campo C; Ruilope LM; Segura J; Rodicio JL; García-Robles R; Garcia-Puig J
    Blood Press; 2003; 12(5-6):277-83. PubMed ID: 14763658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why focus on uric acid?
    Johnson RJ
    Curr Med Res Opin; 2015; 31 Suppl 2():3-7. PubMed ID: 26414730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [URATE AS A POTENTIAL RISK FACTOR OF CARDIOVASCULAR AND RENAL DISEASES].
    Butković M
    Acta Med Croatica; 2016 Dec; 70(4-5):233-9. PubMed ID: 29087102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia and Hypertension, Coronary Artery Disease, Kidney Disease: From Concept to Practice.
    Gaubert M; Bardin T; Cohen-Solal A; Diévart F; Fauvel JP; Guieu R; Sadrin S; Maixent JM; Galinier M; Paganelli F
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 33561034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Part 1. Uric acid and losartan.
    Sica DA; Schoolwerth AC
    Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):475-82. PubMed ID: 12187310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of angiotensin II receptor blockers on hyperuricemia.
    Wolff ML; Cruz JL; Vanderman AJ; Brown JN
    Ther Adv Chronic Dis; 2015 Nov; 6(6):339-46. PubMed ID: 26568810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into uric acid effects on the progression and prognosis of chronic kidney disease.
    Filiopoulos V; Hadjiyannakos D; Vlassopoulos D
    Ren Fail; 2012; 34(4):510-20. PubMed ID: 22260409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Antihypertensive Drugs on Uric Acid Metabolism in Patients with Hypertension: Cross-Sectional Cohort Study.
    Ueno S; Hamada T; Taniguchi S; Ohtani N; Miyazaki S; Mizuta E; Ohtahara A; Ogino K; Yoshida A; Kuwabara M; Yoshida K; Ninomiya H; Kotake H; Taufiq F; Yamamoto K; Hisatome I
    Drug Res (Stuttg); 2016 Dec; 66(12):628-632. PubMed ID: 27643410
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy.
    Lee TH; Chen JJ; Wu CY; Yang CW; Yang HY
    Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34574015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA).
    Tanaka A; Taguchi I; Hisauchi I; Yoshida H; Shimabukuro M; Hongo H; Ishikawa T; Kadokami T; Yagi S; Sata M; Node K;
    Eur J Med Res; 2023 Jul; 28(1):238. PubMed ID: 37461063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.
    Johnson RJ; Kivlighn SD; Kim YG; Suga S; Fogo AB
    Am J Kidney Dis; 1999 Feb; 33(2):225-34. PubMed ID: 10023633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid: role in cardiovascular disease and effects of losartan.
    Alderman M; Aiyer KJ
    Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricemia: a novel old disorder-relationship and potential mechanisms in heart failure.
    Borghi C; Palazzuoli A; Landolfo M; Cosentino E
    Heart Fail Rev; 2020 Jan; 25(1):43-51. PubMed ID: 31745840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperuricemia, urate deposition and the association with hypertension.
    Mancia G; Grassi G; Borghi C
    Curr Med Res Opin; 2015; 31 Suppl 2():15-9. PubMed ID: 26414732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum uric acid--a cardiovasular risk factor?].
    Alderman M; Redfern JS
    Ther Umsch; 2004 Sep; 61(9):547-52. PubMed ID: 15493113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome.
    Masajtis-Zagajewska A; Majer J; Nowicki M
    J Renin Angiotensin Aldosterone Syst; 2021; 2021():2214978. PubMed ID: 34527078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.